Genovese Elizabeth A, Avgerinos Efthymios D, Baril Donald T, Makaroun Michel S, Chaer Rabih A
Division of Vascular Surgery, Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Division of Vascular Surgery, Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Vascular. 2016 Dec;24(6):590-597. doi: 10.1177/1708538116630859. Epub 2016 Feb 18.
There is limited investigation into the use of bio-absorbable antibiotic beads for the treatment of prosthetic vascular graft infections. Our goal was to investigate the rates of infection eradication, graft preservation, and limb salvage in patients who are not candidates for graft explant or extensive reconstruction.
A retrospective review of patients implanted with antibiotic impregnated bio-absorbable calcium sulfate beads at a major university center was conducted.
Six patients with prosthetic graft infections were treated with bio-absorbable antibiotics beads from 2012-2014. Grafts included an aortobifemoral, an aorto-hepatic/superior mesenteric artery, and four extra-anatomic bypasses. Pathogens included Gram-positive and Gram-negative bacteria. Half of the patients underwent graft explant with reconstruction and half debridement of the original graft, all with antibiotic bead placement around the graft. Mean follow-up was 7.3 ± 8.3 months; all patients had infection resolution, healed wounds, and 100% graft patency, limb salvage, and survival.
This report details the successful use of bio-absorbable antibiotic beads for the treatment prosthetic vascular graft infections in patients at high risk for graft explant or major vascular reconstruction. At early follow-up, we demonstrate successful infection suppression, graft preservation, and limb salvage with the use of these beads in a subset of vascular patients.
关于使用生物可吸收抗生素珠治疗人工血管移植感染的研究有限。我们的目标是调查那些不适合进行移植体取出或广泛重建的患者的感染根除率、移植体保留率和肢体挽救率。
对在一所主要大学中心植入含抗生素的生物可吸收硫酸钙珠的患者进行回顾性研究。
2012年至2014年,6例人工血管移植感染患者接受了生物可吸收抗生素珠治疗。移植体包括1例主-双股动脉移植、1例主-肝/肠系膜上动脉移植和4例解剖外旁路移植。病原体包括革兰氏阳性菌和革兰氏阴性菌。一半患者接受了移植体取出并重建,另一半患者对原移植体进行了清创,所有患者均在移植体周围放置了抗生素珠。平均随访时间为7.3±8.3个月;所有患者感染均得到解决,伤口愈合,移植体通畅率、肢体挽救率和生存率均为100%。
本报告详细介绍了生物可吸收抗生素珠在移植体取出或重大血管重建高风险患者中成功用于治疗人工血管移植感染的情况。在早期随访中,我们证明了在一部分血管疾病患者中使用这些珠子可成功抑制感染、保留移植体并挽救肢体。